MedPath
FDA Approval

HEMICLOR

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 27, 2025
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Chlorthalidone(12.5 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

PRM Pharma LLC

118256253

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Ingenus Pharmaceuticals NJ, LLC

Ingenus Pharmaceuticals, LLC

PRM Pharma LLC

964680206

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

HEMICLOR

Product Details

NDC Product Code
50742-285
Application Number
NDA218647
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
March 27, 2025
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
Code: Q0MQD1073QClass: ACTIBQuantity: 12.5 mg in 1 1
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
SODIUM STARCH GLYCOLATE TYPE AInactive
Code: H8AV0SQX4DClass: IACT
CALCIUM STEARATEInactive
Code: 776XM7047LClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
© Copyright 2025. All Rights Reserved by MedPath